论文部分内容阅读
目的 评估双侧髂内动脉灌注化疗 +手术在治疗浸润性膀胱肿瘤中的价值。方法 对 11例浸润性膀胱肿瘤患者行双侧髂内动脉灌注化疗 +手术。结果 术后 11例随访 1～ 3年。 1年时死亡 1例 ,1例多发膀胱肿瘤患者于术后 3个月复发 ,第 3次做灌注化疗 ;余 9例 2年内死亡 4例 ,5例生存 3年以上。 1年存活率 91%。结论 双侧髂内动脉灌注化疗治疗浸润性膀胱肿瘤 ,安全可靠 ,不良反应小 ,可延缓病情发展 ,为手术切除肿瘤提供宝贵的时机 ,两者结合 ,可成为治疗浸润性膀胱肿瘤的首选方法
Objective To evaluate the value of bilateral internal iliac arterial infusion chemotherapy in the treatment of invasive bladder cancer. Methods 11 cases of invasive bladder cancer patients underwent bilateral iliac artery infusion chemotherapy + surgery. Results 11 cases were followed up for 1-3 years. One patient died at one year, one patient with multiple bladder cancer recurred 3 months after operation and the third infusion chemotherapy. In the remaining nine patients, 4 patients died in 2 years and 5 patients survived for 3 years. 1 year survival rate of 91%. Conclusions Bilateral internal iliac arterial infusion chemotherapy for invasive bladder cancer is safe and reliable with small adverse reactions, which can delay the progression of the disease and provide a precious opportunity for surgical resection of the tumor. The combination of the two can be the preferred method of treatment of invasive bladder cancer